PERSISTENCE WITH BISPHOSPHONATE THERAPY AND RISK OF HIP FRACTURE

被引：0
|
作者：
Chodick, G. [1 ]
Shalev, V [1 ]
Sharon, Y. [2 ]
Goldstein, I [1 ]
机构：
[1] Maccabi Healthcare Serv, Tel Aviv, Israel
[2] Tel Aviv Univ, IL-69978 Tel Aviv, Israel
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 03期
关键词：
D O I：
10.1016/j.jval.2011.02.691
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A124 / A124
页数：1
相关论文
共 50 条
  • [41] Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women
    Rabenda, V.
    Reginster, J. -Y.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S19 - S20
  • [42] Chronic acid-suppressive therapy and the risk of hip fracture
    Yang, YX
    Lewis, JD
    Epstein, S
    Metz, DC
    GASTROENTEROLOGY, 2005, 128 (04) : A138 - A138
  • [43] Prophylactic surgery for a bisphosphonate-related atypical hip fracture
    Miura, L. N.
    Srikantom, S. V.
    Schenck, J.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2013, 61 : S24 - S24
  • [44] Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women
    Rabenda, V.
    Mertens, R.
    Fabri, V.
    Vanoverloop, J.
    Sumkay, F.
    Vannecke, C.
    Deswaef, A.
    Verpooten, G. A.
    Reginster, J. -Y.
    OSTEOPOROSIS INTERNATIONAL, 2008, 19 (06) : 811 - 818
  • [45] Estrogen replacement therapy and the risk of hip fracture in old age
    Boonen, S
    Pelemans, W
    Dequeker, J
    AGING-CLINICAL AND EXPERIMENTAL RESEARCH, 1996, 8 (01): : 70 - 71
  • [46] Long-term PPI therapy and the risk of hip fracture
    Graber, Mark A.
    Dachs, Robert
    Darby-Stewart, Andrea
    AMERICAN FAMILY PHYSICIAN, 2008, 77 (03) : 277 - 278
  • [47] Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women
    V. Rabenda
    R. Mertens
    V. Fabri
    J. Vanoverloop
    F. Sumkay
    C. Vannecke
    A. Deswaef
    G. A. Verpooten
    J.-Y. Reginster
    Osteoporosis International, 2008, 19 : 811 - 818
  • [48] The impact of the duration of bisphosphonate drug holidays on hip fracture rates
    Curtis, Jeffrey R.
    Chen, Rui
    Li Zixu
    Arora, Tarun
    Saag, Kenneth G.
    Wright, Nicole
    Daigle, Shanette
    Kilgore, Meredith
    Delzell, Elizabeth
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 40 - 40
  • [49] Warfarin therapy and risk of hip fracture among elderly patients
    Mamdani, M
    Upshur, REG
    Anderson, G
    Bartle, BR
    Laupacis, A
    PHARMACOTHERAPY, 2003, 23 (01): : 1 - 4
  • [50] Proton pump inhibitor therapy and hip fracture risk - Reply
    Yang, Yu-Xiao
    Lewis, James D.
    Epstein, Solomon
    Metz, David C.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (13): : 1429 - 1430
12345